Literature DB >> 11898580

Selection of anticoagulants or antiplatelet-aggregating agents for prevention of stroke.

Eugene D Kaplan1, Ralph L Sacco.   

Abstract

Stroke is one of leading causes of mortality and morbidity in the United States. Stroke prevention includes treatment of the stroke risk factors and long-term use of antithrombotic agents. Various agents have been studied for stroke prevention and other trials are ongoing. The aim of this article is to provide an overview of the recent guidelines, recommendations, and clinical trial results using antithrombotic therapy for stroke prevention.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11898580     DOI： 10.1007/s11910-002-0050-1

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN： 1528-4042            Impact factor:   5.081


  53 in total

Review 1.  Guide to anticoagulant therapy: Heparin : a statement for healthcare professionals from the American Heart Association.

Authors:  J Hirsh; S S Anand; J L Halperin; V Fuster
Journal:  Circulation       Date:  2001-06-19       Impact factor: 29.690

Review 2.  Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association.

Authors:  J Biller; W M Feinberg; J E Castaldo; A D Whittemore; R E Harbaugh; R J Dempsey; L R Caplan; T F Kresowik; D B Matchar; J F Toole; J D Easton; H P Adams; L M Brass; R W Hobson; T G Brott; L Sternau
Journal:  Circulation       Date:  1998-02-10       Impact factor: 29.690

3.  Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study.

Authors:  R L Sacco; B Boden-Albala; R Gan; X Chen; D E Kargman; S Shea; M C Paik; W A Hauser
Journal:  Am J Epidemiol       Date:  1998-02-01       Impact factor: 4.897

4.  Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial.

Authors:  P M Bath; E Lindenstrom; G Boysen; P De Deyn; P Friis; D Leys; R Marttila; J Olsson; D O'Neill; J Orgogozo; B Ringelstein; J van der Sande; A G Turpie
Journal:  Lancet       Date:  2001-09-01       Impact factor: 79.321

5.  Preventing ischemic stroke in patients with prior stroke and transient ischemic attack : a statement for healthcare professionals from the Stroke Council of the American Heart Association.

Authors:  P A Wolf; G P Clagett; J D Easton; L B Goldstein; P B Gorelick; M Kelly-Hayes; R L Sacco; J P Whisnant
Journal:  Stroke       Date:  1999-09       Impact factor: 7.914

6.  ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation): developed in Collaboration With the North American Society of Pacing and Electrophysiology.

Authors:  V Fuster; L E Rydén; R W Asinger; D S Cannom; H J Crijns; R L Frye; J L Halperin; G N Kay; W W Klein; S Lévy; R L McNamara; E N Prystowsky; L S Wann; D G Wyse; R J Gibbons; E M Antman; J S Alpert; D P Faxon; V Fuster; G Gregoratos; L F Hiratzka; A K Jacobs; R O Russell; S C Smith; W W Klein; A Alonso-Garcia; C Blomström-Lundqvist; G De Backer; M Flather; J Hradec; A Oto; A Parkhomenko; S Silber; A Torbicki
Journal:  J Am Coll Cardiol       Date:  2001-10       Impact factor: 24.094

7.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

8.  A randomized trial of aspirin and sulfinpyrazone in threatened stroke.

Authors: 
Journal:  N Engl J Med       Date:  1978-07-13       Impact factor: 91.245

9.  The efficacy and safety of ticlopidine and aspirin in non-whites: analysis of a patient subgroup from the Ticlopidine Aspirin Stroke Study.

Authors:  L A Weisberg
Journal:  Neurology       Date:  1993-01       Impact factor: 9.910

10.  Randomised trial of prophylactic daily aspirin in British male doctors.

Authors:  R Peto; R Gray; R Collins; K Wheatley; C Hennekens; K Jamrozik; C Warlow; B Hafner; E Thompson; S Norton
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.